• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

AMRrounds: susceptibility to the new tetracycline-derivative eravacycline of New Delhi metallo-β-lactamase-producing complex.

作者信息

Galfo Valentina, Tiseo Giusy, Giordano Cesira, Leonildi Alessandro, Lepore Aurelio, Pogliaghi Manuela, Riccardi Niccolò, Barnini Simona, Falcone Marco

机构信息

Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Pisana, University of Pisa, Pisa, Italy.

Microbiology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

出版信息

JAC Antimicrob Resist. 2025 Aug 28;7(4):dlaf153. doi: 10.1093/jacamr/dlaf153. eCollection 2025 Aug.

DOI:10.1093/jacamr/dlaf153
PMID:40894238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12392884/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9080/12392884/0e78c281e06b/dlaf153f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9080/12392884/0e78c281e06b/dlaf153f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9080/12392884/0e78c281e06b/dlaf153f1.jpg

相似文献

1
AMRrounds: susceptibility to the new tetracycline-derivative eravacycline of New Delhi metallo-β-lactamase-producing complex.抗菌药物耐药性讨论：产新德里金属β-内酰胺酶菌株对新型四环素衍生物依拉环素的敏感性
JAC Antimicrob Resist. 2025 Aug 28;7(4):dlaf153. doi: 10.1093/jacamr/dlaf153. eCollection 2025 Aug.
2
Resistance of Gram-Negative Bacteria to Cefepime-Enmetazobactam: A Systematic Review.革兰氏阴性菌对头孢吡肟-恩美他唑巴坦的耐药性：一项系统评价
Pathogens. 2025 Aug 6;14(8):777. doi: 10.3390/pathogens14080777.
3
Antibacterial activity of eravacycline against isolates: an study.依拉环素对分离株的抗菌活性：一项研究。
Microbiol Spectr. 2025 Jul;13(7):e0256424. doi: 10.1128/spectrum.02564-24. Epub 2025 May 30.
4
ARGONAUT-III and -V: susceptibility of carbapenem-resistant and multidrug-resistant to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime.ARGONAUT-III 和 -V：碳青霉烯类耐药和多重耐药对双环硼酸β-内酰胺酶抑制剂替加环素与头孢吡肟联合用药的敏感性。
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0075124. doi: 10.1128/aac.00751-24. Epub 2024 Aug 12.
5
and screening of new Delhi metallo-β-lactamase-1 inhibitors from endophytic spp.从内生种筛选新德里金属β-内酰胺酶-1 抑制剂
J Biomol Struct Dyn. 2022;40(24):13593-13605. doi: 10.1080/07391102.2021.1990132. Epub 2021 Oct 16.
6
New Delhi metallo-β-lactamase-1-producing isolates in hospitalized patients in Kashan, Iran.伊朗卡尚住院患者中产生新德里金属β-内酰胺酶-1的分离株
Iran J Microbiol. 2017 Oct;9(5):283-287.
7
Comparative activities of omadacycline, eravacycline and tigecycline against non-ESBL-producing, ESBL-producing and carbapenem-resistant isolates of .比较奥马环素、依拉环素和替加环素对非产 ESBL、产 ESBL 和耐碳青霉烯类菌株的活性。
J Med Microbiol. 2022 Oct;71(10). doi: 10.1099/jmm.0.001592.
8
First report of New Delhi metallo-β-lactamase-6 (NDM-6) among Klebsiella pneumoniae ST147 strains isolated from dialysis patients in Iran.首次在伊朗透析患者分离的肺炎克雷伯菌 ST147 株中发现新德里金属β-内酰胺酶 6（NDM-6）。
Infect Genet Evol. 2019 Apr;69:142-145. doi: 10.1016/j.meegid.2019.01.030. Epub 2019 Jan 23.
9
New Delhi Metallo-β-Lactamase 5-Producing Klebsiella pneumoniae Sequence Type 258, Southwest China, 2017.中国西南地区 2017 年携带新型金属β-内酰胺酶 5 的肺炎克雷伯菌 258 型序列类型
Emerg Infect Dis. 2019 Jun;25(6):1209-1213. doi: 10.3201/eid2506.181939.
10
NDM-1 and VIM-1 dual metallo-beta-lactamase producing Klebsiella pneumoniae ST15 high-risk clone from a blood culture of a patient at Intensive Care Unit in a Greek Tertiary Care Hospital.从希腊一家三级护理医院重症监护病房一名患者的血培养物中分离出的产NDM-1和VIM-1双金属β-内酰胺酶的肺炎克雷伯菌ST15高危克隆。
Acta Microbiol Immunol Hung. 2025 Mar 24;72(2):93-98. doi: 10.1556/030.2025.02559. Print 2025 Jun 20.

本文引用的文献

1
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumannii.第三代四环素类药物替加环素、依拉环素和奥马环素对西班牙全国范围内收集的产碳青霉烯酶肠杆菌科细菌和鲍曼不动杆菌的活性及耐药机制
Biomed Pharmacother. 2024 Dec;181:117666. doi: 10.1016/j.biopha.2024.117666. Epub 2024 Dec 2.
2
Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area.产金属β-内酰胺酶肠杆菌科细菌感染的临床特征和结局：来自流行地区的一项为期 3 年的前瞻性研究。
Clin Infect Dis. 2024 May 15;78(5):1111-1119. doi: 10.1093/cid/ciad725.
3
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network).不同碳青霉烯类耐药革兰氏阴性杆菌引起的血流感染所致死亡率：来自意大利全国性研究（ALARICO 网络）的结果。
Clin Infect Dis. 2023 Jun 16;76(12):2059-2069. doi: 10.1093/cid/ciad100.
4
Nosocomial outbreak by NDM-1-producing highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022.2021 年 8 月至 2022 年 6 月，意大利佛罗伦萨发生产 NDM-1 的耐碳青霉烯头孢地尔 洛高度耐药的医院感染爆发。
Euro Surveill. 2022 Oct;27(43). doi: 10.2807/1560-7917.ES.2022.27.43.2200795.
5
Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies.肺炎克雷伯菌对依拉环素耐药的产生及协同治疗策略的伴随敏感性指导设计。
Microbiol Spectr. 2022 Oct 26;10(5):e0139022. doi: 10.1128/spectrum.01390-22. Epub 2022 Aug 16.
6
Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation.意大利托斯卡纳地区一起暴发的与产NDM-1的肺炎克雷伯菌ST147亚系相关的耐药基因组和毒力基因组累积：基因型和表型特征分析
Lancet Microbe. 2022 Mar;3(3):e224-e234. doi: 10.1016/S2666-5247(21)00268-8. Epub 2022 Feb 4.
7
Extremely drug-resistant NDM-9-producing ST147 causing infections in Italy, May 2020.2020 年 5 月，意大利出现了携带 NDM-9 超级耐药基因的 ST147 型超级细菌，引发感染。
Euro Surveill. 2020 Dec;25(48). doi: 10.2807/1560-7917.ES.2020.25.48.2001779.
8
In vitro activity of eravacycline compared with tigecycline against carbapenem-resistant Enterobacteriaceae.依拉环素与替加环素体外抗碳青霉烯类耐药肠杆菌科的活性比较。
Int J Antimicrob Agents. 2020 Dec;56(6):106178. doi: 10.1016/j.ijantimicag.2020.106178. Epub 2020 Sep 25.
9
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales.头孢他啶-阿维巴坦联合氨曲南治疗产金属β-内酰胺酶肠杆菌科血流感染的疗效。
Clin Infect Dis. 2021 Jun 1;72(11):1871-1878. doi: 10.1093/cid/ciaa586.
10
Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing During a Regional Outbreak.新德里金属β-内酰胺酶产生菌引起的血流感染在区域暴发期间的临床特征及转归
Open Forum Infect Dis. 2020 Jan 21;7(2):ofaa011. doi: 10.1093/ofid/ofaa011. eCollection 2020 Feb.